The National Cancer Center of Japan uses the QIAGEN Clinical Insights (QCI) platform including expert-curated evidence knowledge bases, bioinformatics software, and data center infrastructure, to support the C-CAT’s molecular profiling services for core hospitals of the country’s cancer genomic medicine program. QIAGEN has established an in-country data center in Tokyo, compliant with Japanese data security and privacy regulations, to support this national program.